semaglutide prediabetes progression to diabetes trial Remission of type 2 diabetes: position statement of the Italian society of diabetes (SID) SELECT Trial

Recent trends have brought GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), to front of mind when discussing general weight loss, and emerging research has focused on the weight loss aspect of GLP-1 agonists for patients with breast cancer

cGASSTING signaling and function in metabolism and kidney diseases

IGF-1 Test is Safe

Regular walking or other light physical activity may also support healthy digestion

Click the underlined page links if you're interested in learning more about "What is Wegovy?", which is similarly referred to as Ozempic or semaglutide, or about "What is Zepbound?", which is similarly referred to as Mounjaro or tirzepatide